Sign in
IXHL Stock Price, Chart, Stats & News
Incannex Healthcare Limited
Save
38.65M
Market cap
–
Current P/E
3.78x
Forward P/E
IXHL chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 100.00% |
Operating margin | -41819.62% |
Pretax margin | -67722.12% |
Net margin | -67722.12% |
Effective tax rate | – |
ROA | -77.65% |
ROE | -199.09% |
D/E | 0.00x |
Interest coverage ratio | -57.21x |
IXHL valuation
P/E | – |
P/S | 432.68x |
P/B | 0.51x |
P/CF | -2.08x |
P/FCF | -2.05x |
P/OCF | -2.08x |
PEG | -0.01x |
EV multiple | -1.74x |
About
Incannex Healthcare Limited is an Australian company dedicated to the research, development, and commercialization of medicinal cannabinoid products. The firm offers pharmaceutical-grade cannabinoid compounds under its proprietary Incannex brand. Its product pipeline includes several key assets: IHL-42X: This compound is currently undergoing Phase II clinical evaluation for the treatment of obstructive sleep apnea (OSA).
Similar securities
Based on sector and market capitalization
Report issue